IS7267A - Tvívetnis setin díhýdrófúranon og lyf sem innihalda þessi efnasambönd - Google Patents

Tvívetnis setin díhýdrófúranon og lyf sem innihalda þessi efnasambönd

Info

Publication number
IS7267A
IS7267A IS7267A IS7267A IS7267A IS 7267 A IS7267 A IS 7267A IS 7267 A IS7267 A IS 7267A IS 7267 A IS7267 A IS 7267A IS 7267 A IS7267 A IS 7267A
Authority
IS
Iceland
Prior art keywords
dihydrogen
compounds
drugs containing
substituted dihydrofuranone
dihydrofuranone
Prior art date
Application number
IS7267A
Other languages
English (en)
Inventor
Alken Rudolf-Giesbert
Original Assignee
Turicum Drug Development Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Development Ag filed Critical Turicum Drug Development Ag
Publication of IS7267A publication Critical patent/IS7267A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
IS7267A 2001-12-12 2004-05-17 Tvívetnis setin díhýdrófúranon og lyf sem innihalda þessi efnasambönd IS7267A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162120A DE10162120A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Dihydrofuranone sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004591 WO2003050101A1 (de) 2001-12-12 2002-12-11 Deuterierte substituierte dihydrofuranone sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
IS7267A true IS7267A (is) 2004-05-17

Family

ID=7709639

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7267A IS7267A (is) 2001-12-12 2004-05-17 Tvívetnis setin díhýdrófúranon og lyf sem innihalda þessi efnasambönd

Country Status (16)

Country Link
US (1) US7317039B2 (is)
EP (1) EP1456192A1 (is)
JP (1) JP2005511742A (is)
KR (1) KR20040088474A (is)
CN (1) CN1602304A (is)
AU (1) AU2002360900A1 (is)
CA (1) CA2469519A1 (is)
DE (1) DE10162120A1 (is)
HU (1) HUP0402304A2 (is)
IL (1) IL162406A0 (is)
IS (1) IS7267A (is)
NO (1) NO20042907L (is)
NZ (1) NZ533596A (is)
PL (1) PL369139A1 (is)
RU (1) RU2004121032A (is)
WO (1) WO2003050101A1 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
AU2007267612A1 (en) * 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
CA2730734C (en) 2008-07-15 2017-04-25 Theracos, Inc. Deuterated 2,3,4-trihydroxy-tetrahydropyranyl-benzylbenzene compounds having sodium glucose cotransporter inhibitory activity
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
US8227451B2 (en) * 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
US20120244122A1 (en) * 2009-05-28 2012-09-27 Masse Craig E Peptides for the Treatment of HCV Infections
AU2010306927A1 (en) 2009-10-12 2012-05-31 Myrexis, Inc. Amino - pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
CA2801061A1 (en) * 2010-06-01 2011-12-08 Auspex Pharmaceuticals, Inc. Benzoquinolone inhibitors of vmat2
US9694017B2 (en) * 2014-02-10 2017-07-04 Concert Pharmaceuticals, Inc. Substituted triazolobenzodiazepines
JP6810613B2 (ja) * 2014-06-20 2021-01-06 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
BR112020018669A2 (pt) * 2018-03-21 2020-12-29 Izumi Technology, Llc Análogos deuterados de elacridar
EP4025202A4 (en) 2019-09-03 2023-08-02 Intra-Cellular Therapies, Inc. NOVEL CONNECTIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
HUP0402304A2 (hu) 2005-02-28
NO20042907L (no) 2004-07-09
US20050176814A1 (en) 2005-08-11
US7317039B2 (en) 2008-01-08
JP2005511742A (ja) 2005-04-28
WO2003050101A1 (de) 2003-06-19
CN1602304A (zh) 2005-03-30
RU2004121032A (ru) 2006-01-10
KR20040088474A (ko) 2004-10-16
DE10162120A1 (de) 2003-06-18
CA2469519A1 (en) 2003-06-19
EP1456192A1 (de) 2004-09-15
AU2002360900A1 (en) 2003-06-23
IL162406A0 (en) 2005-11-20
NZ533596A (en) 2005-07-29
PL369139A1 (en) 2005-04-18

Similar Documents

Publication Publication Date Title
IS7267A (is) Tvívetnis setin díhýdrófúranon og lyf sem innihalda þessi efnasambönd
IS7304A (is) Tvívetnissetin pýrasólýlbensýlsúlfónamíð og lyf sem innihalda téð efnasambönd
GB0117618D0 (en) Pharmaceutical dosage form
IS7735A (is) Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
FI20011478L (fi) Farmaseuttinen koostumus
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DE60211601D1 (de) Bereitstellung von positionsabhängigen Inhalten
EE200300416A (et) Ravimvorm
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
GB0117619D0 (en) Pharmaceutical dosage form
HUP0302297A3 (en) Substituted thioacetamides and pharmaceutical compositions containing them
ATE352291T1 (de) Filmbildende zusammensetzung, enthaltend sucralose und hydrocolloid
FI20022128L (fi) Farmaseuttinen koostumus
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
ATE285753T1 (de) Lysin enthaltende kautablette
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1392271T3 (da) Slugetablet indeholdende paracetamol
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
IS7246A (is) Tvívetnis pýrasólópýrimidínon og lyf sem innihalda þessi efnasambönd
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
IS6857A (is) Lyfjafræðileg samsetning sem innheldur sítalópram
DE60202793D1 (de) Getterlegierungen sowie vorrichtungen zum verdampfen von kalzium
EE200300564A (et) Püridüülmetüülaminopürimidiiniühendid, nende kasutamine ja ravim